Acta Academiae Medicinae Sinica

Acta Academiae Medicinae Sinica

Acta Academiae Medicinae Sinica ›› 2011, Vol. 33 ›› Issue (4): 468-472.doi: 10.3881/j.issn.1000-503X.2011.04.024

Previous Articles     Next Articles

Metabolic Disorder after Androgen Deprivation Therapy in Patients with Prostate Cancer

YUAN Jiaqi, ZHANG Xiaowei, XU Tao, WANG Xiaofeng   

  1. Department of Urology, Peking University Peoples Hospital, Beijing 100044, China
  • Received:2010-08-23 Revised:2011-09-05 Online:2011-08-01 Published:2011-08-01
  • Contact: XU Tao E-mail:xutao@medmail.com.cn

Abstract: The prevalence of prostate cancer, a common malignancy of urinary system in elderly males, has increased rapidly in China in recent years. Currently most prostate cancer patients are treated with androgen deprivation therapy (ADT). However, ADT-induced metabolic disorders such as metabolic syndrome has remarkably impaired the quality of life and decreased the survival rate.

Key words: prostate cancer, androgen deprivation therapy, metabolic syndrome, osteoporosis

CLC Number: